Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
H9N2 AA ca Reassortant
- Development stage
- Phase 1
- Lead developer
- Centers for Disease Control and Prevention
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intranasal, Intramuscular
01
Overview
H9N2 AA ca Reassortant refers to a type of genetically modified avian influenza virus (H9N2 subtype) that has undergone genetic reassortment, often engineered to be cold-adapted ('ca'). This viral construct is primarily developed as a vaccine candidate to induce an immune response against H9N2 influenza virus. H9N2 avian influenza is endemic in poultry populations and poses a significant threat to both animal health and public health due to its zoonotic potential and its ability to contribute genes to other emerging influenza viruses. The vaccine aims to stimulate the production of specific antibodies and cellular immune responses to provide protection against infection.
- Other names
- H9N2 reassortant virusH-9N2 reassortant virusH 9N2 reassortant virus
02
Targets
H9 HA (Influenza A hemagglutinin H9)N2 (Influenza A neuraminidase N2)
Beyond the preview
Go deeper on H9N2 AA ca Reassortant.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on H9N2 AA ca Reassortant.